How Committed Is Your University to Access to Medicines?

Join this webinar to learn about the role universities play in access to medicines, what UAEM has done to increase access, and how to join the research team for 2027.

What to expect?

• Alumni look back on past UAEM projects
• UAEM North America presents the University Access Dashboard they have created
• UAEM Europe introduces the start of the European edition of the Dashboard
• Find out how you can join the project!

Universities receive billions in public funding for biomedical research. Yet the health technologies that come out of that research are often licensed to private companies whose priorities may not match public health needs. When that happens, monopoly pricing and other access barriers can keep patients from benefiting from medicines public funding helped create.The result is a system that reflects global injustice, and the people at the intersection of international systems of discrimination pay the highest price.

It doesn’t have to work that way. Universities can shape who gets access through the terms of their licensing agreements, and students can push them to do better.

UAEM has experience evaluating university commitment to equitable access policies, and we are launching the next European chapter now.